✦ LIBER ✦

Vedolizumab for the treatment of active ulcerative colitis: A randomized controlled phase 2 dose-ranging study

✍ Scribed by Asit Parikh; Timothy Leach; Tim Wyant; Catherine Scholz; Serap Sankoh; Diane R. Mould; Terry Ponich; Irving Fox; Brian G. Feagan

Book ID: 112101210
Publisher: John Wiley and Sons
Year: 2012
Tongue: English
Weight: 480 KB
Volume: 18
Category: Article
ISSN: 1078-0998
DOI: 10.1002/ibd.21896

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Budesonide enema for the treatment of ac

Budesonide enema for the treatment of active, distal ulcerative colitis and proctitis: A dose-ranging study

✍ Stephen B. Hanauer; Malcolm Robinson; Ronald Pruitt; Audrey J. Lazenby; Tore Per 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 138 KB

Low-molecular-weight heparin (enoxaparin

Low-molecular-weight heparin (enoxaparin) as adjuvant therapy in the treatment of active ulcerative colitis: a randomized, controlled, comparative study

✍ P. ZEZOS; G. PAPAIOANNOU; N. NIKOLAIDIS; K. PATSIAOURA; A. PAPAGEORGIOU; T. VASS 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 200 KB

Clinical trial: a multicentre, randomize

Clinical trial: a multicentre, randomized, double-blind, placebo-controlled, dose-finding, phase II study of subcutaneous interferon-β-1a in moderately active ulcerative colitis

✍ C. PENA-ROSSI; S. SCHREIBER; G. GOLUBOVIC; A. MERTZ-NIELSEN; J. PANES; D. RACHMI 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 224 KB

Bifidogenic growth stimulator for the tr

Bifidogenic growth stimulator for the treatment of active ulcerative colitis: a pilot study

✍ Asuka Suzuki; Keiichi Mitsuyama; Hironori Koga; Nobuo Tomiyasu; Junya Masuda; Ko 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 142 KB

A phase II, randomized, double-blind, pl

A phase II, randomized, double-blind, placebo-controlled, dose-ranging study of belimumab in patients with active systemic lupus erythematosus

✍ Wallace, Daniel J. ;Stohl, William ;Furie, Richard A. ;Lisse, Jeffrey R. ;McKay, 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 372 KB 👁 2 views

## Abstract ## Objective To assess the safety, tolerability, biologic activity, and efficacy of belimumab in combination with standard of care therapy (SOC) in patients with active systemic lupus erythematosus (SLE). ## Methods Patients with a Safety of Estrogens in Lupus Erythematosus: National

A Phase II dose ranging, double-blind, p

A Phase II dose ranging, double-blind, placebo-controlled study of alicaforsen enema in subjects with acute exacerbation of mild to moderate left-sided ulcerative colitis

✍ S. J. H. VAN DEVENTER; M. K. WEDEL; B. F. BAKER; S. XIA; E. CHUANG; P. B. MINER 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 213 KB